Annual report pursuant to Section 13 and 15(d)

Subsequent Events (Details Narrative)

v3.20.1
Subsequent Events (Details Narrative) - USD ($)
$ / shares in Units, $ in Thousands
 1 Months Ended 12 Months Ended
Feb. 06, 2020
Feb. 13, 2019
Mar. 27, 2020
Feb. 21, 2020
Jan. 22, 2020
Dec. 31, 2019
Dec. 31, 2018
Exercise price (in dollars per share)           $ 3.78 $ 3.31
Expected term, in years           5 years 9 months 18 days 5 years 9 months 18 days
Percentage of materials           50.00%  
Restricted Stock Units (RSUs) [Member]              
Expected term, in years   4 years          
Subsequent Event [Member]              
Number of shares issued       15,070      
License agreement, description         The Company entered into a license agreement (the "Shared Space Agreement") with Orchestra BioMed, Inc., a greater than 5% holder of our common stock and in which David Hochman, the Chairman of our board of directors, served as the Chairman of the board of directors, and Darren Sherman, a member of our board of directors, served as a director and chief operating officer, to grant the use of 35% of the Fort Lauderdale premises and shall expand to approximately 60% to 70% of the premises during the term.    
License agreement expire date         Sep. 14, 2024    
License fees         $ 29    
Percentage of materials     50.00%        
Subsequent Event [Member] | Warrant [Member]              
Number of shares issued 120,000            
Expected term, in years 3 years            
Subsequent Event [Member] | Warrant [Member] | Issuance [Member]              
Exercise price (in dollars per share) $ 2.16            
Number of shares approved for issuance 60,000            
Subsequent Event [Member] | Warrant [Member] | Issuance One [Member]              
Exercise price (in dollars per share) $ 3.50            
Number of shares approved for issuance 60,000            
Subsequent Event [Member] | Restricted Stock Units (RSUs) [Member]              
Number of shares issued       15,070      
Subsequent Event [Member] | Minimum [Member]              
License fees         12    
Subsequent Event [Member] | Maximum [Member]              
License fees         $ 17    
Subsequent Event [Member] | Executives And Directors [Member]              
Number of shares issued 260,153            
Exercise price (in dollars per share) $ 2.16            
Expected term, in years 3 years            
Subsequent Event [Member] | Executive [Member] | Restricted Stock Units (RSUs) [Member]              
Number of shares approved for issuance 260,153            
Subsequent Event [Member] | Employee [Member]              
Exercise price (in dollars per share) $ 2.16            
Number of shares approved for issuance 831,014